• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期生命中肠道微生物组的发育:囊性纤维化和抗生素治疗的影响。

Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatment.

机构信息

Department of Pediatric pulmonology, Wilhelmina Children's Hospital, University Medical Center Utrecht, the Netherlands.

Department of Pediatric pulmonology, Wilhelmina Children's Hospital, University Medical Center Utrecht, the Netherlands.

出版信息

J Cyst Fibros. 2020 Jul;19(4):553-561. doi: 10.1016/j.jcf.2020.04.007. Epub 2020 May 30.

DOI:10.1016/j.jcf.2020.04.007
PMID:32487494
Abstract

OBJECTIVES

Patients with Cystic Fibrosis (CF) suffer from pancreatic insufficiency, lipid malabsorption and gastrointestinal complaints, next to progressive pulmonary disease. Altered mucosal homoeostasis due to malfunctioning chloride channels results in an adapted microbial composition of the gastrointestinal and the respiratory tract. Additionally, antibiotic treatment has the potential to distort resident microbial communities dramatically. This study aims to investigate early life development of the gut microbial community composition of children with CF compared to healthy infants and to study the independent effects of antibiotics taking into account other clinical and lifestyle factors.

STUDY DESIGN

Faecal samples from 20 infants with CF and 45 healthy infants were collected regularly during the first 18 months of life and microbial composition was determined using 16S rRNA based sequencing.

RESULTS

We observed significant differences in the overall microbiota composition between infants with CF and healthy infants (p<0.001). Akkermansia and Anaerostipes were significantly more abundant in control infants, whereas Streptococci and E. coli were significantly more abundant in infants with CF, also after correction for several clinical factors (p<0.05). Antibiotic use in infants with CF was associated with a lower alpha diversity, a reduced abundance of Bifidobacterium and Bacteroides, and a higher abundance of Enterococcus.

CONCLUSION

Microbial development of the gut is different in infants with CF compared to healthy infants from the first months of life on, and further deviates over time, in part as a result of antibiotic treatment. The resulting dysbiosis may have significant functional consequences for the microbial ecosystem in CF patients.

摘要

目的

囊性纤维化(CF)患者除了进行性肺部疾病外,还患有胰腺功能不全、脂肪吸收不良和胃肠道问题。由于氯离子通道功能障碍导致的黏膜稳态改变,导致胃肠道和呼吸道的微生物组成发生适应性改变。此外,抗生素治疗有可能显著改变定植微生物群落。本研究旨在比较 CF 患儿与健康婴儿的早期肠道微生物群落组成,并研究抗生素的独立作用,同时考虑其他临床和生活方式因素。

研究设计

收集 20 名 CF 患儿和 45 名健康婴儿在生命的前 18 个月内定期的粪便样本,并使用基于 16S rRNA 的测序技术来确定微生物组成。

结果

我们观察到 CF 患儿和健康婴儿之间的总体微生物群落组成存在显著差异(p<0.001)。阿克曼氏菌和厌氧棒状菌在对照组婴儿中明显更丰富,而链球菌和大肠杆菌在 CF 患儿中明显更丰富,即使在纠正了几个临床因素后也是如此(p<0.05)。CF 患儿的抗生素使用与较低的 alpha 多样性、双歧杆菌和拟杆菌丰度降低以及肠球菌丰度增加有关。

结论

从生命的第一个月开始,CF 患儿的肠道微生物发育与健康婴儿不同,并且随着时间的推移进一步偏离,部分原因是抗生素治疗。由此产生的生态失调可能对 CF 患者的微生物生态系统产生重大功能影响。

相似文献

1
Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatment.早期生命中肠道微生物组的发育:囊性纤维化和抗生素治疗的影响。
J Cyst Fibros. 2020 Jul;19(4):553-561. doi: 10.1016/j.jcf.2020.04.007. Epub 2020 May 30.
2
Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype.囊性纤维化中的肠道微生物组特征:宿主 CFTR 功能丧失导致微生物组肠病表型。
PLoS One. 2018 Dec 6;13(12):e0208171. doi: 10.1371/journal.pone.0208171. eCollection 2018.
3
The altered gut microbiota in adults with cystic fibrosis.患有囊性纤维化的成年人肠道微生物群的改变
BMC Microbiol. 2017 Mar 9;17(1):58. doi: 10.1186/s12866-017-0968-8.
4
Altered Stool Microbiota of Infants with Cystic Fibrosis Shows a Reduction in Genera Associated with Immune Programming from Birth.囊性纤维化婴儿的粪便微生物组发生改变,从出生起与免疫编程相关的属减少。
J Bacteriol. 2019 Jul 24;201(16). doi: 10.1128/JB.00274-19. Print 2019 Aug 15.
5
Gut microbiota in adults with cystic fibrosis: Implications for the severity of the CFTR gene mutation and nutritional status.成人囊性纤维化的肠道微生物群:对 CFTR 基因突变和营养状况严重程度的影响。
J Cyst Fibros. 2024 Sep;23(5):977-983. doi: 10.1016/j.jcf.2024.06.016. Epub 2024 Jul 3.
6
Prominent role of gut dysbiosis in the pathogenesis of cystic fibrosis-related liver disease in mice.肠道菌群失调在小鼠囊性纤维化相关性肝病发病机制中的突出作用。
J Hepatol. 2024 Sep;81(3):429-440. doi: 10.1016/j.jhep.2024.03.041. Epub 2024 Mar 28.
7
Development of the intestinal microbiome in cystic fibrosis in early life.婴儿期囊性纤维化的肠道微生物组发育。
mSphere. 2023 Aug 24;8(4):e0004623. doi: 10.1128/msphere.00046-23. Epub 2023 Jul 5.
8
Development of the Nasopharyngeal Microbiota in Infants with Cystic Fibrosis.婴儿期囊性纤维化患者鼻咽微生物组的发育。
Am J Respir Crit Care Med. 2016 Mar 1;193(5):504-15. doi: 10.1164/rccm.201509-1759OC.
9
Statistical Evaluation of Metaproteomics and 16S rRNA Amplicon Sequencing Techniques for Study of Gut Microbiota Establishment in Infants with Cystic Fibrosis.统计评估宏蛋白质组学和 16S rRNA 扩增子测序技术在研究囊性纤维化婴儿肠道微生物组建立中的应用。
Microbiol Spectr. 2022 Dec 21;10(6):e0146622. doi: 10.1128/spectrum.01466-22. Epub 2022 Oct 18.
10
An medium for modeling gut dysbiosis associated with cystic fibrosis.用于模拟与囊性纤维化相关的肠道菌群失调的培养基。
J Bacteriol. 2024 Jan 25;206(1):e0028623. doi: 10.1128/jb.00286-23. Epub 2024 Jan 3.

引用本文的文献

1
The Prevalence of Polyketide Synthase-Positive in Cystic Fibrosis.囊性纤维化中聚酮合酶阳性的患病率
Microorganisms. 2025 Mar 18;13(3):681. doi: 10.3390/microorganisms13030681.
2
Effectiveness of Probiotics, Prebiotics, and Symbiotic Supplementation in Cystic Fibrosis Patients: A Systematic Review and Meta-Analysis of Clinical Trials.益生菌、益生元及合生元补充剂对囊性纤维化患者的疗效:一项临床试验的系统评价与荟萃分析
Medicina (Kaunas). 2025 Mar 12;61(3):489. doi: 10.3390/medicina61030489.
3
A New Insight into Phage Combination Therapeutic Approaches Against Drug-Resistant Mixed Bacterial Infections.
噬菌体联合治疗耐药混合细菌感染方法的新见解
Phage (New Rochelle). 2024 Dec 18;5(4):203-222. doi: 10.1089/phage.2024.0011. eCollection 2024 Dec.
4
Effects of Therapeutic Antibiotic Exposure on the Oropharyngeal and Fecal Microbiota in Infants With Cystic Fibrosis.治疗性抗生素暴露对囊性纤维化婴儿口咽和粪便微生物群的影响。
Pediatr Pulmonol. 2025 Mar;60(3):e71024. doi: 10.1002/ppul.71024.
5
Regulation effect of the intestinal flora and intervention strategies targeting the intestinal flora in alleviation of pulmonary fibrosis development.肠道菌群的调节作用及针对肠道菌群的干预策略在减轻肺纤维化进展中的作用
Biosci Microbiota Food Health. 2024;43(4):293-299. doi: 10.12938/bmfh.2023-100. Epub 2024 Mar 14.
6
Respiratory diseases and gut microbiota: relevance, pathogenesis, and treatment.呼吸系统疾病与肠道微生物群:相关性、发病机制及治疗
Front Microbiol. 2024 Jul 16;15:1358597. doi: 10.3389/fmicb.2024.1358597. eCollection 2024.
7
Diagnosis and Management of Gastrointestinal Manifestations in Children with Cystic Fibrosis.囊性纤维化患儿胃肠道表现的诊断与管理
Diagnostics (Basel). 2024 Jan 22;14(2):228. doi: 10.3390/diagnostics14020228.
8
Longitudinal profiling of the intestinal microbiome in children with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor.囊性纤维化患儿接受依伐卡托韦-泰他卡托韦-艾美卡替治疗后的肠道微生物组纵向分析。
mBio. 2024 Feb 14;15(2):e0193523. doi: 10.1128/mbio.01935-23. Epub 2024 Jan 26.
9
Intestinal modulates inflammation, systemic cytokines, and microbial ecology via propionate in a mouse model of cystic fibrosis.肠道通过丙酸调节囊性纤维化小鼠模型中的炎症、系统细胞因子和微生物生态。
mBio. 2024 Feb 14;15(2):e0314423. doi: 10.1128/mbio.03144-23. Epub 2024 Jan 5.
10
An medium for modeling gut dysbiosis associated with cystic fibrosis.用于模拟与囊性纤维化相关的肠道菌群失调的培养基。
J Bacteriol. 2024 Jan 25;206(1):e0028623. doi: 10.1128/jb.00286-23. Epub 2024 Jan 3.